Back to User profile » Prof. Dr. Yukio Yuzawa
Papers published by Prof. Dr. Yukio Yuzawa:
Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer’s Disease
Kitaguchi N, Kawaguchi K, Sakata M, Aoki H, Yamazaki K, Kaneko M, Kinomura J, Kato M, Hasegawa M, Suzuki N, Mizuno M, Yuzawa Y
Neuropsychiatric Disease and Treatment 2021, 17:2291-2308
Published Date: 13 July 2021
Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease
Saito Y, Sakata M, Kobayakawa M, Kawachi H, Kawaguchi K, Hiki Y, Kato M, Mori M, Hasegawa M, Ohashi N, Yuzawa Y, Kitaguchi N
Neuropsychiatric Disease and Treatment 2020, 16:607-627
Published Date: 3 March 2020
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K
Neuropsychiatric Disease and Treatment 2018, 14:2931-2937
Published Date: 1 November 2018
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2017, 10:1001-1002
Published Date: 21 February 2017
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2015, 8:1701-1706
Published Date: 10 July 2015
Efficacy and safety of febuxostat in elderly female patients
Mizuno T, Hayashi T, Hikosaka S, Shimabukuro Y, Murase M, Takahashi K, Hayashi H, Yuzawa Y, Nagamatsu T, Yamada S
Clinical Interventions in Aging 2014, 9:1489-1493
Published Date: 4 September 2014
Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease
Mizuno T, Hayashi T, Kato R, Noguchi A, Hayashi H, Yuzawa Y, Yamada S, Nagamatsu T
Therapeutics and Clinical Risk Management 2014, 10:73-76
Published Date: 30 January 2014